Selected research
Industry Research
Clonal Selection Services Industry Research Report 2026
Market perspective
The global Clonal Selection Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Clonal Selection Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Clonal Selection Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Clonal Selection Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Clonal Selection Services include Clean Cells, Bio-Techne, PixelBiosciences GmbH, Biofidus AG, Lonza, Azenta, Creative Biogene, OriGene and Samsung Biologics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Clonal Selection Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Clonal Selection Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Clonal Selection Services Market by Company
Clean Cells
Bio-Techne
PixelBiosciences GmbH
Biofidus AG
Lonza
Azenta
Creative Biogene
OriGene
Samsung Biologics
Catalent
Genscript
Eurofins Genomics
Takara Bio
Clonal Selection Services Segment by Type
Single Cell Isolation
Cloning Expansion
Others
Clonal Selection Services Segment by Application
Biopharmaceutical Process Development
Cell Line Development
Others
Clonal Selection Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clonal Selection Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clonal Selection Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clonal Selection Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Clonal Selection Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single Cell Isolation
- Cloning Expansion
- Others
Applications
- Biopharmaceutical Process Development
- Cell Line Development
- Others
Companies covered
- Clean Cells
- Bio-Techne
- PixelBiosciences GmbH
- Biofidus AG
- Lonza
- Azenta
- Creative Biogene
- OriGene
- Samsung Biologics
- Catalent
- Genscript
- Eurofins Genomics
- Takara Bio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Clonal Selection Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Single Cell Isolation
- 2.2.3 Cloning Expansion
- 2.2.4 Others
- 2.3 Clonal Selection Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceutical Process Development
- 2.3.3 Cell Line Development
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Clonal Selection Services Breakdown Data by Type
- 3.1 Global Clonal Selection Services Historic Market Size by Type (2021-2026)
- 3.2 Global Clonal Selection Services Forecasted Market Size by Type (2027-2032)
4 Clonal Selection Services Breakdown Data by Application
- 4.1 Global Clonal Selection Services Historic Market Size by Application (2021-2026)
- 4.2 Global Clonal Selection Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Clonal Selection Services Market Perspective (2021-2032)
- 5.2 Global Clonal Selection Services Growth Trends by Region
- 5.2.1 Global Clonal Selection Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Clonal Selection Services Historic Market Size by Region (2021-2026)
- 5.2.3 Clonal Selection Services Forecasted Market Size by Region (2027-2032)
- 5.3 Clonal Selection Services Market Dynamics
- 5.3.1 Clonal Selection Services Industry Trends
- 5.3.2 Clonal Selection Services Market Drivers
- 5.3.3 Clonal Selection Services Market Challenges
- 5.3.4 Clonal Selection Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Clonal Selection Services Players by Revenue
- 6.1.1 Global Top Clonal Selection Services Players by Revenue (2021-2026)
- 6.1.2 Global Clonal Selection Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Clonal Selection Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Clonal Selection Services Head Office and Area Served
- 6.4 Global Clonal Selection Services Players, Product Type & Application
- 6.5 Global Clonal Selection Services Manufacturers Established Date
- 6.6 Global Clonal Selection Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Clonal Selection Services Market Size (2021-2032)
- 7.2 North America Clonal Selection Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Clonal Selection Services Market Size by Country (2021-2026)
- 7.4 North America Clonal Selection Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Clonal Selection Services Market Size (2021-2032)
- 8.2 Europe Clonal Selection Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Clonal Selection Services Market Size by Country (2021-2026)
- 8.4 Europe Clonal Selection Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Clonal Selection Services Market Size (2021-2032)
- 9.2 Asia-Pacific Clonal Selection Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Clonal Selection Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Clonal Selection Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Clonal Selection Services Market Size (2021-2032)
- 10.2 South America Clonal Selection Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Clonal Selection Services Market Size by Country (2021-2026)
- 10.4 South America Clonal Selection Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Clonal Selection Services Market Size (2021-2032)
- 11.2 Middle East & Africa Clonal Selection Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Clonal Selection Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Clonal Selection Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Clean Cells
- 12.1.1 Clean Cells Company Information
- 12.1.2 Clean Cells Business Overview
- 12.1.3 Clean Cells Revenue in Clonal Selection Services Business (2021-2026)
- 12.1.4 Clean Cells Clonal Selection Services Product Portfolio
- 12.1.5 Clean Cells Recent Developments
- 12.2 Bio-Techne
- 12.2.1 Bio-Techne Company Information
- 12.2.2 Bio-Techne Business Overview
- 12.2.3 Bio-Techne Revenue in Clonal Selection Services Business (2021-2026)
- 12.2.4 Bio-Techne Clonal Selection Services Product Portfolio
- 12.2.5 Bio-Techne Recent Developments
- 12.3 PixelBiosciences GmbH
- 12.3.1 PixelBiosciences GmbH Company Information
- 12.3.2 PixelBiosciences GmbH Business Overview
- 12.3.3 PixelBiosciences GmbH Revenue in Clonal Selection Services Business (2021-2026)
- 12.3.4 PixelBiosciences GmbH Clonal Selection Services Product Portfolio
- 12.3.5 PixelBiosciences GmbH Recent Developments
- 12.4 Biofidus AG
- 12.4.1 Biofidus AG Company Information
- 12.4.2 Biofidus AG Business Overview
- 12.4.3 Biofidus AG Revenue in Clonal Selection Services Business (2021-2026)
- 12.4.4 Biofidus AG Clonal Selection Services Product Portfolio
- 12.4.5 Biofidus AG Recent Developments
- 12.5 Lonza
- 12.5.1 Lonza Company Information
- 12.5.2 Lonza Business Overview
- 12.5.3 Lonza Revenue in Clonal Selection Services Business (2021-2026)
- 12.5.4 Lonza Clonal Selection Services Product Portfolio
- 12.5.5 Lonza Recent Developments
- 12.6 Azenta
- 12.6.1 Azenta Company Information
- 12.6.2 Azenta Business Overview
- 12.6.3 Azenta Revenue in Clonal Selection Services Business (2021-2026)
- 12.6.4 Azenta Clonal Selection Services Product Portfolio
- 12.6.5 Azenta Recent Developments
- 12.7 Creative Biogene
- 12.7.1 Creative Biogene Company Information
- 12.7.2 Creative Biogene Business Overview
- 12.7.3 Creative Biogene Revenue in Clonal Selection Services Business (2021-2026)
- 12.7.4 Creative Biogene Clonal Selection Services Product Portfolio
- 12.7.5 Creative Biogene Recent Developments
- 12.8 OriGene
- 12.8.1 OriGene Company Information
- 12.8.2 OriGene Business Overview
- 12.8.3 OriGene Revenue in Clonal Selection Services Business (2021-2026)
- 12.8.4 OriGene Clonal Selection Services Product Portfolio
- 12.8.5 OriGene Recent Developments
- 12.9 Samsung Biologics
- 12.9.1 Samsung Biologics Company Information
- 12.9.2 Samsung Biologics Business Overview
- 12.9.3 Samsung Biologics Revenue in Clonal Selection Services Business (2021-2026)
- 12.9.4 Samsung Biologics Clonal Selection Services Product Portfolio
- 12.9.5 Samsung Biologics Recent Developments
- 12.10 Catalent
- 12.10.1 Catalent Company Information
- 12.10.2 Catalent Business Overview
- 12.10.3 Catalent Revenue in Clonal Selection Services Business (2021-2026)
- 12.10.4 Catalent Clonal Selection Services Product Portfolio
- 12.10.5 Catalent Recent Developments
- 12.11 Genscript
- 12.11.1 Genscript Company Information
- 12.11.2 Genscript Business Overview
- 12.11.3 Genscript Revenue in Clonal Selection Services Business (2021-2026)
- 12.11.4 Genscript Clonal Selection Services Product Portfolio
- 12.11.5 Genscript Recent Developments
- 12.12 Eurofins Genomics
- 12.12.1 Eurofins Genomics Company Information
- 12.12.2 Eurofins Genomics Business Overview
- 12.12.3 Eurofins Genomics Revenue in Clonal Selection Services Business (2021-2026)
- 12.12.4 Eurofins Genomics Clonal Selection Services Product Portfolio
- 12.12.5 Eurofins Genomics Recent Developments
- 12.13 Takara Bio
- 12.13.1 Takara Bio Company Information
- 12.13.2 Takara Bio Business Overview
- 12.13.3 Takara Bio Revenue in Clonal Selection Services Business (2021-2026)
- 12.13.4 Takara Bio Clonal Selection Services Product Portfolio
- 12.13.5 Takara Bio Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst